61 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 61 of 61 clinical reviews.
A complete guide to Aetna (CVS Health) coverage for generic tadalafil, including formulary tier, prior authorization criteria, step therapy requirements, appeal strategies, and real out-of-pocket cost comparisons.
A clinical and practical guide to Blue Cross Blue Shield Federated coverage of generic tadalafil, including formulary tiers, prior authorization criteria, step therapy requirements, and how to appeal a denial.
State Medicaid coverage for generic tadalafil varies widely. Learn which states cover tadalafil for ED and BPH, prior authorization requirements, formulary tiers, step therapy rules, and how to appeal a denial.
UnitedHealthcare typically covers generic tadalafil on Tier 3 with prior authorization. Learn formulary placement, PA criteria, step therapy rules, appeal steps, and cost-saving strategies.
A complete guide to obtaining generic tadalafil in Massachusetts, including telehealth options, pharmacy access, prescribing requirements, insurance coverage, and cost-saving strategies for MA residents.
A clinical guide to obtaining generic tadalafil in New Hampshire via telehealth, local pharmacies, and 503A compounding. Covers prescribing rules, labs, insurance, and shipping timelines, with a checklist for verifying facts that change over time.
A guide to getting a tadalafil (generic Cialis) prescription in New Mexico, including telehealth rules, pharmacy access, insurance coverage, and clinical details for ED and BPH treatment.
A guide to obtaining generic tadalafil in North Carolina through telehealth, in-person clinics, and licensed pharmacies. Covers dosing, labs, costs, and prescriber rules under NC law.
A guide to obtaining generic tadalafil in Pennsylvania: telehealth prescribing rules, retail and compounding pharmacy options, insurance and Medicaid prior authorization, and which facts to re-verify before you rely on them.
Evidence-based guidance on stopping tadalafil 2.5-20 mg safely, including when tapering matters, what symptoms to expect, and how to manage the return of ED or BPH symptoms after discontinuation.
Evidence-based monitoring protocols for adolescents aged 12 to 17 prescribed tadalafil, covering baseline labs, cardiovascular checks, growth velocity tracking, and mental-health screening.
Tadalafil is not FDA-approved for erectile dysfunction or BPH in patients aged 12-17. This article reviews the limited evidence, off-label considerations, and the one pediatric indication where tadalafil data does exist.
A guide to monitoring tadalafil 2.5 to 20 mg in adults aged 30 to 49: when to check blood pressure, PSA, liver enzymes, and cardiovascular risk, with dose-specific safety thresholds and follow-up intervals.
Evidence-based tadalafil dosing guide for adults aged 30-49, covering daily low-dose and on-demand protocols for erectile dysfunction and BPH.
Tadalafil is an oral PDE5 inhibitor for ED and BPH. Learn how it works, when it fails, and how intracavernosal injection (ICI) therapy serves as the evidence-based next step, including full self-injection technique.
A practical guide to clinically significant tadalafil drug interactions, from absolute contraindications with nitrates to CYP3A4-mediated dosing cautions, organized by what a prescriber or patient actually needs to decide.
What tadalafil (generic) costs in Alabama in 2026, from retail cash prices to compounded options. Covers Medicaid, insurance, telehealth access, and discount programs.
What does generic tadalafil cost in Alaska in 2026? Compare retail cash prices, compounded options, Medicaid coverage, insurance tiers, and telehealth access across the state.
What generic tadalafil costs in Arizona in 2026, from retail pharmacy cash prices to compounded options, insurance coverage, Medicaid status, and discount programs.
What does generic tadalafil cost in Idaho in 2026? Compare cash-pay pharmacy prices, compounded tadalafil options, insurance coverage, Medicaid status, and discount programs across Idaho.
What is stable and what is not yet verified about generic tadalafil pricing, Medicaid coverage, compounding, and telehealth access in Nebraska, with a checklist for confirming current numbers before you fill a prescription.
What is actually known about generic tadalafil pricing, insurance coverage, and access in New Hampshire, with a checklist for verifying current numbers before you rely on them.
What tadalafil (generic) costs in Virginia in 2026, from retail cash prices to Medicaid coverage, compounded options, and telehealth access across the state.
What tadalafil (generic) costs in Wisconsin in 2026. Cash prices, Medicaid coverage, insurance options, compounded tadalafil, telehealth access, and discount programs for WI residents.
Current tadalafil generic pricing in Wyoming for 2026, including cash-pay costs, Medicaid coverage status, compounded options, and discount programs.
Compare the cost of generic tadalafil against sildenafil, vardenafil, and avanafil. Includes pricing context, clinical efficacy data, and guidance on choosing among PDE5 inhibitors.
How to dose generic tadalafil for adults aged 50 to 64, including daily vs. on-demand protocols, drug interactions, cardiovascular screening, and BPH overlap.
A guide to tadalafil 2.5 to 20 mg dosing for men aged 18 to 29, covering on-demand vs. daily regimens, fertility considerations, BPH overlap, safety, and a clinician-discussion framework for monitoring.
Evidence-based guidance on tadalafil 2.5 to 20 mg dosing adjustments for patients with Child-Pugh A, B, and C hepatic impairment. Covers pharmacokinetics, safety, and prescribing recommendations backed by FDA labeling and primary literature.
Evidence-based guide to tadalafil dose adjustments in kidney disease, covering mild, moderate, and severe renal impairment plus dialysis patients, with FDA label data and primary-source citations.
Evidence-based guide to tadalafil food and supplement interactions, including grapefruit, alcohol, L-arginine, St. John's Wort, and CYP3A4 pathways, with sourcing limits clearly marked.
A guide to monitoring tadalafil 2.5 to 20 mg in patients aged 65 and older, covering renal function, falls risk, drug interactions, blood pressure, and deprescribing thresholds.
Evidence-based guide to tadalafil dosing in older adults (65+), covering starting doses, renal adjustments, drug interactions, fall risk, and BPH considerations.
A guide to tadalafil 2.5 to 20 mg safety in adults aged 65 and older, covering dose adjustments, fall risk, drug interactions, renal function, and deprescribing guidance.
A deep dive into how tadalafil 2.5 to 20 mg was discovered, developed, and approved, covering mechanism, key clinical trials, and what generic availability means for patients today.
Evidence-based guide to prescribing generic tadalafil in transplant recipients, HIV-positive patients, chronic kidney disease, hepatic impairment, spinal cord injury, diabetes, and post-prostatectomy populations.
A clinical review of generic tadalafil's manufacturing base, FDA supply chain data, and documented shortage episodes from patent expiry through 2026.
A physician-level breakdown of how tadalafil 2.5 to 20 mg works, from PDE5 inhibition and cGMP signaling to smooth-muscle relaxation, BPH relief, and the pharmacokinetics behind its 36-hour window.
What the tadalafil label and general PDE5 inhibitor pharmacology support about missed doses for daily and on-demand regimens, including when to skip, when to resume, and when to call a prescriber.
A guide to monitoring tadalafil 2.5 to 20 mg in men aged 18 to 29, covering cardiovascular checks, hormone panels, fertility considerations, and when to escalate care.
A guide to the complete monitoring schedule for generic tadalafil (2.5 to 20 mg) covering baseline labs, cardiovascular screening, follow-up exams, drug interactions, and special populations.
A guide to tadalafil's off-label applications beyond ED and BPH, graded by clinical evidence from RCTs, meta-analyses, and guideline endorsements.
A guide to monitoring tadalafil 2.5 to 20 mg in adults aged 50, 64, covering cardiovascular safety, drug interactions, BPH/ED overlap, andropause, and lab checkpoints with primary-source citations.
Evidence-based guide to tadalafil overdose recognition, pharmacokinetics at supratherapeutic doses, and supportive management. Covers accidental double-dosing, intentional excess, and when to seek emergency care.
Tadalafil has no FDA-approved pediatric indication for children under 12. This evidence review covers off-label dosing research in pulmonary arterial hypertension, safety data, and monitoring requirements for prescribing clinicians.
Evidence-based guide to monitoring tadalafil in pediatric patients under 12, covering off-label PAH use, weight-based dosing, hepatic surveillance, hemodynamic tracking, and growth assessment.
An evidence-based review of tadalafil (generic) safety in pediatric patients under 12, covering FDA labeling, the STARTS trials, off-label risks, weight-based dosing considerations, and monitoring protocols.
How CYP3A4, CYP3A5, and PDE5A polymorphisms influence tadalafil metabolism, efficacy, and side-effect risk. Evidence-based guidance for clinicians considering pharmacogenomic testing.
Is tadalafil safe during pregnancy or breastfeeding? Review FDA labeling, animal reproductive data, human evidence, and clinical guidance for tadalafil in reproductive contexts.
A clinical review of real-world evidence for generic tadalafil 2.5-20 mg across erectile dysfunction and BPH, including registry studies, claims analyses, and post-market safety data.
A clinician-level breakdown of how generic tadalafil 2.5 to 20 mg is regulated across the United States, European Union, Canada, and the United Kingdom, including approval dates, scheduling, and prescribing implications.
A guide to tadalafil 2.5 to 20 mg safety for adults aged 30, 49, covering contraindications, drug interactions, cardiovascular risk, side effects, and dosing guidance backed by trial data.
Evidence-based safety guide for generic tadalafil (2.5-20 mg) in adults aged 50-64, covering cardiovascular risks, drug interactions, dose adjustments, and monitoring protocols.
A clinical review of tadalafil generic safety in men aged 18 to 29, covering dosing, side effects, cardiovascular risk, fertility, and long-term use considerations.
Evidence-based review of tadalafil (generic) safety considerations for adolescents aged 12-17, including off-label use, pharmacokinetics, monitoring protocols, and clinical guidance.
FDA labeling lists organic nitrates as an absolute contraindication with tadalafil; nitrates must be deferred at least 48 hours after a tadalafil dose.
How to store generic tadalafil 2.5 to 20 mg correctly, what the stability data shows, when tablets degrade, and what that means for efficacy and safety, with PubMed and FDA citations.
A clinician-level guide to switching between tadalafil, sildenafil, vardenafil, and avanafil, covering pharmacology, timing, dosing, and real trial data to help patients and prescribers make safe, effective transitions.
A clinical review of emerging tadalafil formulations, novel delivery systems, combination therapies, and pipeline developments beyond the standard 2.5-20 mg oral tablet.
A clinical deep-dive into tadalafil's patent expiration, Paragraph IV challenges, and the generic timeline from 2017 onward, with FDA and trial-cited evidence.
Showing the first 60 matches. Use search or filters to narrow the library.